AGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA Starting Material

News, Company News, Partnership

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility.

AGC Biologics Names Regina Choi-Rivera General Manager of Boulder Facility

News, Company News

AGC Biologics today announced Regina Choi-Rivera as the new General Manager of the company’s large-scale biopharmaceutical mammalian production facility in Boulder. In this role, she assumes executive oversight and leadership and will manage strategic development and facility operations.

AGC Biologics Appoints Whitney Sandberg as the new Vice President of Quality for its Colorado Facilities

Company News

AGC Biologics today announced Whitney Sandberg has been appointed as the company’s Vice President for Quality in Colorado. In this position she will have executive oversight for quality operations at the company’s two facilities in the state, located in Boulder and Longmont. Both facilities provide AGC Biologics critical resources for serving its global clientele, and Sandberg’s expertise will ensure each location produces products of the highest quality that meet global GMP requirements and industry expectations.

4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab

News, Company News

AGC Biologics to produce Procizumab for early and late clinical Phases at the company’s Chiba and Copenhagen facilities

Follow Us
Join us on LinkedIn Follow us on Twitter